Literature DB >> 33095353

Surgery for IDH1/2 wild-type glioma invading the corpus callosum.

Pamela Franco1,2, Daniel Delev3, Debora Cipriani4,5, Nicolas Neidert4,5, Elias Kellner5,6, Waseem Masalha4,5, Bianca Mercas4,5, Irina Mader5,7, Peter Reinacher5,8, Astrid Weyerbrock5, Christian Fung4,5, Jürgen Beck4,5, Dieter Henrik Heiland4,5, Oliver Schnell4,5.   

Abstract

BACKGROUND: Glioblastoma of the corpus callosum (ccGBM) are rare tumors, with a dismal prognosis marked by a rapid clinical deterioration. For a long time, surgical treatment was not considered beneficial for most patients with such tumors. Recent studies claimed an improved survival for patients undergoing extensive resection, albeit without integration of the molecular profile of the lesions. The purpose of this study was to investigate the effect of biopsy and surgical resection on oncological and functional outcomes in patients with IDH wild-type ccGBM.
METHODS: We performed a retrospective analysis of our institution's database of patients having been treated for high-grade glioma between 2005 and 2017. Inclusion criteria were defined as follows: patients older than 18 years, histopathological, and molecularly defined IDH wild-type glioma, major tumor mass (at least 2/3) invading the corpus callosum in the sagittal plane with a uni- or bilateral infiltration of the adjacent lobules. Surgical therapy (resection vs. biopsy), extent of resection according to the remaining tumor volume and adjuvant treatment as well as overall survival and functional outcome using the Karnofsky Performance Score (KPS) were analyzed.
RESULTS: Fifty-five patients were included in the study, from which the mean age was 64 years and men (n = 34, 61.8%) were more often affected than women (n = 21, 38.2%). Thirty (54.5%) patients were treated with stereotactic biopsy alone, while 25 patients received tumor resection resulting in 14.5% (n = 8) gross-total resections and 30.9% (n = 17) partial resections. The 2-year survival rate after resection was 30% compared to 7% after biopsy (p = 0.047). The major benefit was achieved in the group with gross-total resection, while partial resection failed to improve survival. Neurological outcome measured by KPS did not differ between both groups either pre- or postoperatively.
CONCLUSIONS: Our study suggests that in patients with corpus callosum glioblastoma, gross-total resection prolongs survival without negatively impacting neurological outcome as compared to biopsy.

Entities:  

Keywords:  Butterfly glioblastoma; Corpus callosum glioblastoma; Extent of resection; Glioblastoma; IDH status; Molecular diagnosis; Neurosurgery

Mesh:

Substances:

Year:  2020        PMID: 33095353      PMCID: PMC7966629          DOI: 10.1007/s00701-020-04623-z

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.816


  5 in total

Review 1.  Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature.

Authors:  Paolo Palmisciano; Gianluca Ferini; Gina Watanabe; Christian Ogasawara; Emal Lesha; Othman Bin-Alamer; Giuseppe E Umana; Kenny Yu; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh; Ali S Haider
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

2.  Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum.

Authors:  Meng Cui; Hewen Chen; Guochen Sun; Jialin Liu; Meng Zhang; Hepu Lin; Caihong Sun; Xiaodong Ma
Journal:  Acta Neurochir (Wien)       Date:  2021-10-12       Impact factor: 2.816

3.  Impact of surgical resection of butterfly glioblastoma on survival: a meta-analysis based on comparative studies.

Authors:  Rafał Chojak; Marta Koźba-Gosztyła; Katarzyna Słychan; Daniel Gajos; Marek Kotas; Michał Tyliszczak; Bogdan Czapiga
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

4.  An Equivocal SCC Lesion-Antiepileptic-Induced CLOCC.

Authors:  Maryla Kuczyńska; Monika Zbroja; Weronika Cyranka; Izabela Halczuk; Ewa Kopyto; Iwona Halczuk; Anna Drelich-Zbroja
Journal:  Brain Sci       Date:  2022-03-13

Review 5.  Surgery vs. Biopsy in the Treatment of Butterfly Glioblastoma: A Systematic Review and Meta-Analysis.

Authors:  Shreya Chawla; Vasileios K Kavouridis; Alessandro Boaro; Rasika Korde; Sofia Amaral Medeiros; Heba Edrees; Elisabetta Mezzalira; Francesco Sala; Rania A Mekary; Timothy R Smith
Journal:  Cancers (Basel)       Date:  2022-01-09       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.